Insights on the DNA Gyrase Subunit B (EC 5.99.1.3) Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027

The global DNA gyrase subunit B (EC 5.99.1.3) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). DNA gyrase is an essential bacterial enzyme that belongs to the topoisomerases class of enzymes that controls the topological transitions of DNA. Additionally, it catalyzes the ATP-dependent negative super-coiling of double-stranded closed-circular DNA. The major factor accelerating the growth of the market is the increasing prevalence of bacterial infections across the globe.

Moreover, based on application, the market is segmented into bacterial infections, clostridium diffclie infections, klebsiella pneumoniae infections, and others. Clostridium diffclie infections are anticipated to hold a major share in the market due to the rising incidence rate. According to the National Center for Biotechnology Information (NCBI), in 2017, there was an estimated 235,700 cases with an estimated incidence rate of 73.3 per 100,000 population in the US.

To Request a Sample of our Report on DNA Gyrase Subunit B (EC 5.99.1.3) Market: https://www.omrglobal.com/request-sample/dna-gyrase-subunit-b-ec-59913-market

Some major players in the market include Bristol-Myers Squibb Co., AstraZeneca Plc, and Merck & Co., Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in October 2019, GlaxoSmithKline Plc announced the beginning of patient dosing in a phase III clinical programme investigating gepotidacin. Gepotidacin is a new chemical class of antibiotics called triazaacenaphthylene bacterial topoisomerase inhibitors used for the treatment of patients with uncomplicated urinary tract infection and urogenital gonorrhoea (GC). The drug works by interacting with two key bacterial enzymes, DNA gyrase and topoisomerase IV

Market Coverage

• The market number available for - 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

Segment Covered-

· By Type

· By Application

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- Bristol-Myers Squibb Co., AstraZeneca Plc, and Merck & Co., Inc., among others.

(Get 15% Discount on Buying this Report)

A full Report of DNA Gyrase Subunit B (EC 5.99.1.3) Market is Available @ https://www.omrglobal.com/industry-reports/dna-gyrase-subunit-b-ec-59913-market

Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Report by Segment

By Type

• GYR-12

• DS-2969

• VXC-100

• VT-12008911

• Others

By Application

• Bacterial Infections

• Clostridium Diffclie Infections

• Klebsiella Pneumoniae Infections

• Others

Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.